| [1] Shou D,Dong Y,Shen L,et al.Rapid quantification of tobramycin and vancomycin by UPLC-TQD and application to osteomyelitis patient samples.J Chromatogr Sci.2014;52(6):501． [2] Chang SS,Tsai MC,Chiu CH,et al.Endoscopically assisted allogeneic bone grafting for atrophic nonunion of femur and tibia.Formosan J Musculoskel Dis. 2012;2(3):94． [3] McKee MD,Li-Bland EA,Wild LM,et al.A prospective， randomized clinical trial comparing an antibiotic- impregnated bioabsorbable bone substitute with standard antibiotic-impregnated cement beads in the treatment of chronic osteomyelitis and infected nonunion.J Orthop Trauma.2010;24(8):483． [4] Malloy KM, Davis GA．Summary of ASHP /IDSA /SIDP vancomycin Monitoring recommendations: a focus on osteomyelitis.Orthopedics.2009;32(7):499． [5] Assor M.Noncemented total knee arthroplasty with a local prophylactic anti-infection agent: a prospective series of 135 cases.Can J Surg.2010;53(1):47. [6] Nandi SK,Mukherjee P,Roy S,et al.Local antibiotic delivery systems for the treatment of osteomyelitis-A review.Mater Sci Eng C.2009;29(8):2478． [7] Yang Y,Zhao H,Zhou J.Treatment of displaced intraarticular calcaneal fractures with or without bone grafts: A systematic review of the literature.Indian J Orthop.2012; 46(2):130-137. [8] Panchbhavi VK.Synthetic bone grafting in foot and ankle surgery.Foot Ankle Clin. 2010;15(4):559-576. [9] Zhao L,Wu C,Wang F,et al.Fabrication of biofunctional complex micelles with tunable structure for application in controlled drug release.Colloid Polym Sci.2014; 292(7):1675-1683. [10] Noh K,Brammer KS,Choi C,et al.A New Nano-Platform for Drug Release via Nanotubular Aluminum Oxide.J Biomater Nanobiotechnol.2011;2(3):226-233. [11] Aw MS,Kurian M,Losic D,et al.Non-eroding drug-releasing implants with ordered nanoporous and nanotubular structures: concepts for controlling drug release.Biomater Sci.2013;2(1):10-34. [12] Aw MS,Losic D.Ultrasound enhanced release of therapeutics from drug-releasing implants based on titania nanotube arrays.IntJ Pharm. 2013;443(1-2): 154-162. [13] Larsson S,Hannink G.Injectable bone-graft substitutes: current products, their characteristics and indications, and new developments.Injury.2011;42(Suppl 2): S30-S40. [14] Goff T, Kanakaris NK, Giannoudis PV. Use of bone graft substitutes in the management of tibial plateau fractures.Injury.2013;44(Suppl 1):S86-S94. [15] Jansen J,Ooms E,Verdonschot N,et al.Injecctable calcium phosphate cement for bone repair and implant fixation.Orthop Clin North Am.2005;36(1):89-95. [16] Lerner T,Griefingholt H,Liljenqvist U. Bone substitutes in scoliosis surgery. Orthopade.2009;38(2):181-188. [17] Civinini R,De Biase P,Carulli C,et al.The use of an injectable calcium sulphate/calcium phosphate bioceramic in the treatment of osteonecrosis of the femoral head.Int Orthop.2012;36(8):1583-1588. [18] Fillingham YA,Lenart BA,Gitelis S.Function after injection of benign bone lesions with a bioceramic.Clin Orthop Relat Res.2012;470(7):2014-2020. [19] Turner TM,Urban RM,Hall DJ,et al.Local and systemic levels of tobramycin delivered from calcium sulfate bone graft substitute pellets.Clin Orthop Relat Res. 2005;437(437):97-104. [20] Beardmore AA,Brooks DE,Wenke JC,et al. Effectiveness of local antibiotic delivery with an osteoinductive and osteoconductive bone-graft substitute.J Bone Joint Surg Am. 2005;87(1):107-112. [21] Sanicola SM,Albert SF.The in vitro elution characteristics of vancomycin and tobramycin from calcium sulfate beads. J Foot Ankle Surg. 2005;44(2):121-124. [22] Hu G,Xiao L,Fu H,et al.Study on injectable and de-gradable cement of calcium sulphate and calcium phosphate for bone repair.J Mater Sci Mater Med.2010; 21(2):627-634. [23] Chitsazi MT,Shirmohammadi A,Faramarzie M,et al.A clinical comparison of nano-crystalline hydroxyapatite (Ostim) and autogenous bone graft in the treatment of periodontal intrabony defects.Med Oral Patol Oral Cir Bucal.2011;16(3):e448-e453. [24] Sun L,Xu HH,Takagi S,et al.Fast setting calcium phosphate cement-chitosan composite: mechanical properties and dissolution rates.J Biomater Appl. 2007; 21(3): 299-315. [25] Jia WT,Luo SH,Zhang CQ,et al.In vitro and in vivo efficacies of teicoplanin-loaded calcium sulfate for treatment of chronic methicillin-resistant staphylococcus aureus osteomyelitis. Antimicrob Agents Chemother.2010;54(1):170-176. [26] Moom SA,Jonas AM,Dusan L,et al.Polymer micelles for delayed release of therapeutics from drug-releasing surfaces with nanotubular structures.Macromolecular Bioscience.2012;12(8):1048-1052. [27] Nandi SK,Roy S,Mukherjee P,et al.Orthopaedic applications of bone graft & graft substitutes: a review. Indian J Med Res.2010;132(7):15-30. [28] Müller MA,Frank A,Briel M,et al.Substitutes of structural and non-structural autologous bone grafts in hindfoot arthrodeses and osteotomies: a systematic review.Bmc Musculoskel Dis.2013;14(1):1-10. [29] Bibbo C,Patel DV.The effect of demineralized bone matrix-calcium sulfate with vancomycin on calcaneal fracture healing and infection rates: a prospective study. Foot Ankle Int.2006;27(7):487-493. [30] Dong H,Tang G,Ma T,et al.One-step fabrication of inorganic/organic hybrid microspheres with tunable surface texture for controlled drug release application.J Mater Sci Mater Med.2016;27(1):1-8. |
.jpg)
.jpg)